<DOC>
	<DOCNO>NCT01453244</DOCNO>
	<brief_summary>The aim study investigate relationship drug response host genetic factor , viral factor clinical factor chronic hepatitis C patient ( HCV ) . And thus , investigator try develop pharmacogenomic guideline Korean patient HCV .</brief_summary>
	<brief_title>Pharmacogenomic Research Korean Patients With Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Hepatitis C virus infect patient Patients infected Hepatitis B virus Human immunodeficiency virus HCV infect patient previously treat antiviral drug Patients history autoimmune hemolytic anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Pharmacogenomics</keyword>
	<keyword>IL28B</keyword>
	<keyword>ITPA</keyword>
</DOC>